Company Active LTD

Company profile

Oviva UK Limited

Oviva UK Limited is a UK company with status active founded in 2015 based in London.

CRN
09667784
Founded
2015
Age
11

Overview

Legal name
OVIVA UK LIMITED
Region
London
Registered address
RUNWAY EAST
20 ST. THOMAS STREET
LONDON
ENGLAND
SE1 9RS
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Oviva UK Limited
CRN 09667784
2
Direct and ultimate controller
CHE-442.270.754
CRN CHE-442.270.754

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

15 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

08 Jun
2026

Notification Of A Person With Significant Control Statement

Persons-with-significant-control

PSC08 | Transaction MzUyNTg5MDg0MGFkaXF6a2N4

Published 08 Jun 2026 11:47

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

01 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

02 Sep
2024

Accounts With Accounts Type Small

Accounts Awaiting analysis

AA | Transaction MzQzNDExNDcwNGFkaXF6a2N4

Published 02 Sep 2024 08:47

02 Jul
2015

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2016
Funded years
2016, 2018, 2019, 2020, 2022
Age at first award
0 years

Projects

2022 Collaborative R&D Lead participant

SAFE-LCD: Can the combination of continuous glucose monitoring and a digital low calorie diet programme make Type 2 diabetes remission achievable and safe in people on insulin therapy?

1 Dec 2022 to 31 May 2025

Awarded
£282,396
Total cost £403,423

Type 2 diabetes (T2D) affects 4.1 million people in the UK, with many requiring medication to help control their blood sugars, and those with advanced T2D requiring daily insulin injections. Insulin treatment is linked to poorer quality of life and increased risk of complications due to disease progression. Longer-term, T2D is associated with a range of d...

2020 Feasibility Studies Lead participant

Can a digital and IoT-enabled behaviour change programme achieve >15kg weight loss and 70% type 2 diabetes remission rates?

1 Jun 2020 to 30 Nov 2020

Awarded
£55,193
Total cost £55,193

no public description

2019 Collaborative R&D Lead participant

Can a digital and IoT-enabled behaviour change programme achieve >15kg weight loss and 70% type 2 diabetes remission rates?

1 Sep 2019 to 28 Feb 2022

Awarded
£229,419
Total cost £327,741

"Type 2 diabetes (DM2) affects 4.1 million people in the UK. DM2 can be hard to manage, with many people needing more than one medication to control their blood sugars, which often come with medications to manage high blood pressure or cholesterol. Furthermore, people are also often receiving treatment for other conditions linked to their DM2 such as kidn...

2018 Collaborative R&D

GM Diabetes My Way

1 Oct 2018 to 31 Mar 2021

Awarded
£80,921
Total cost £115,602

"Approximately 150,000 people in Greater Manchester have type 2 diabetes. The GM Diabetes MyWay project is a collaborative led by the Greater Manchester & Eastern Cheshire Strategic Clinical Networks (SCN) and aims to support these people. It would do this by providing a one-stop digital platform (MyDiabetesMyWay web site) designed to help people self-man...

2018 Collaborative R&D

South London Diabetes Test Bed

1 Oct 2018 to 31 Mar 2020

Awarded
£70,659
Total cost £100,941

"Clinicians and managers are working together across South London to develop innovative ways of managing a growing number of people with diabetes. With a population of over 3 million, there are 159,819 people identified as having either Type 1 or Type 2 diabetes and managing the growing impact is a major clinical challenge. For most people with diabetes, ...

2018 Feasibility Studies Lead participant

Oviva Diabetes Support: Evaluating clinical outcomes for people with type 2 diabetes following completion of a remote programme of structured education and behaviour change

1 Feb 2018 to 31 May 2019

Awarded
£51,738
Total cost £73,911

"Oviva Diabetes Support is a patient-centred, digitally enabled programme of structured education and behaviour change for people with type 2 diabetes. Delivered 1-to-1 by dietitians, the programme provides individualised care over 10-12 weeks to support completion of a defined curriculum and help the participant learn to manage their condition. It is hig...

2016 Collaborative R&D

Diabetes Digital Coach

1 May 2016 to 31 Jul 2018

Awarded
£111,628
Total cost £159,469

The Diabetes Digital Coach Test Bed will provide the infrastructure for mobile health self-management tools (wearable sensors and supporting software) to take advantage of new developments in connecting monitoring devices (Internet of Things) so people with Type 1 or Type 2 diabetes 'do the right thing at the right time' to self-manage their condition. An...

Product types

Collaborative R&D Feasibility Studies